Seqera

Seqera is the driving force behind Nextflow, MultiQC, and the Seqera Platform - the modern biotech stack. Seqera empowers scientists to solve today's most complex and essential challenges; from pioneering innovative therapeutics to unveiling the secrets of our universe. Across personalized immunogenic vaccines and new diagnostics, our customers are performing the most critical work on this planet. We believe in a future in which scientific tools and open datasets combine to deliver incredible outcomes.

Where we come from: It started with Nextflow, an effort to solve problems with reproducible workflows and developed by our founders Paolo Di Tommaso and Evan Floden at Barcelona's Centre for Genomic Regulation (CRG) in 2013. Since then Nextflow has grown into a solution used by tens of thousands of bioinformaticians, clinicians, and data scientists worldwide. Today, Nextflow boasts a vibrant user and developer community including nf-core and is used by the world's leading pharmaceutical, healthcare, and biotech research firms.

In 2018, we founded Seqera to empower scientists with modern software engineering and data analysis tools built on an open-science foundation. Leveraging the deep knowledge of high-throughput analysis and modern software engineering gained from building Nextflow, we have created the Seqera Cloud and Seqera Enterprise platform to make data-intensive research scalable, flexible, and collaborative.